Immediate Impact

3 by Nobel laureates 12 from Science/Nature 55 standout
Sub-graph 1 of 23

Citing Papers

Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial
2023 Standout
DNA Functional Materials Assembled from Branched DNA: Design, Synthesis, and Applications
2020 Standout
2 intermediate papers

Works of Armin Schultz being referenced

Multiple Rising Doses of Oral BI 425809, a GlyT1 Inhibitor, in Young and Elderly Healthy Volunteers: A Randomised, Double-Blind, Phase I Study Investigating Safety and Pharmacokinetics
2018
Nongenomic Steroid Action: Controversies, Questions, and Answers
2003

Author Peers

Author Last Decade Papers Cites
Armin Schultz 62 224 80 189 157 24 667
D. E. Van Orden 63 108 83 137 104 26 603
Katya B. Rubinow 64 167 95 89 289 35 734
Seiji Muro 46 211 59 100 183 37 765
Geetanjali Sharma 34 282 86 426 240 23 814
Antonella Caruso 48 217 47 356 349 20 825
M I Evans 59 277 75 315 83 18 680
Roberto Towns 25 203 152 110 174 25 714
Angélica Morales 84 218 103 84 114 24 742
Rong Li 52 223 75 49 172 38 703
Francesca Nardi 13 167 139 214 119 25 764

All Works

Loading papers...

Rankless by CCL
2026